Skip to main content
Nexphoria
PT-141 10mg

NEXPHORIA

PT-141

Bremelanotide — approved melanocortin agonist. MC3R/MC4R CNS research compound.

For Research Use Only
$54.00per vial

Purchase Type

Fresh cold-chain delivery every 30 days

Format

≥98.5%
HPLC Verified
Cold-Chain
For Research Use Only

For Research Use Only — Not For Human Consumption

This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.

PT-141 (Bremelanotide) is the C-terminal free acid form of Melanotan-II. FDA-approved in 2019 under the tradename Vyleesi (Palatin Technologies / AMAG Pharmaceuticals) for hypoactive sexual desire disorder (HSDD) in premenopausal women, making it the first melanocortin-based approved therapy. As a research compound, PT-141 is used to study MC3R and MC4R signaling pathways.

Side-by-Side Analysis

Compare PT-141 with Similar Compounds

View purity, MW, storage, and pricing side by side.

Frequently Bought Together

Complete Your Protocol

Researchers commonly order these compounds together. Convenient multi-compound ordering.

PT-141

Wellness

This item

PT-141

10mg

$54

Kisspeptin-10

Wellness

Recommended

Kisspeptin-10

5mg

$50

Melanotan-II

Wellness

Melanotan-II

10mg

$48

PT-141Kisspeptin-10Melanotan-II

3 items selected

$152

Uncheck any item to customize your bundle. Discount applied automatically at checkout.

Complete Your Protocol

Hormonal Research Stack

PT-141's melanocortin receptor activation and Kisspeptin's GnRH-stimulating activity represent complementary pathways in sexual function and hormone axis research.

PT-141
Current

Wellness

PT-141

10mg

$54

+
stack
Kisspeptin-10

Wellness

Kisspeptin-10

5mg

$50

$104
View Kisspeptin-10

RUOFor Research Use Only (RUO) — Not for human consumption, clinical use, diagnostic use, or veterinary applications.